Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
India · Delayed Price · Currency is INR 113.50
+1.88 (1.68%)
Sep 11, 2026, 3:29 PM IST
NSE:LOTUSEYE Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 0.8 | 7.39 | 29.15 | 40.78 | 29.85 |
Depreciation & Amortization | 37.07 | 29.88 | 37.01 | 29.81 | 25.01 |
Other Amortization | 0.42 | 0.19 | 0.27 | - | - |
Other Operating Activities | -2.44 | -4.35 | -10.03 | -6.29 | -3.29 |
Change in Accounts Receivable | 1.15 | -0.65 | -0.86 | -5.48 | 1.21 |
Change in Inventory | -0.04 | -6.18 | -4.21 | -4.85 | -5.26 |
Change in Accounts Payable | -1.15 | -1.71 | 3.84 | -4.11 | 3.56 |
Change in Other Net Operating Assets | -5.65 | 2.41 | 1.68 | -5.97 | -6.96 |
Operating Cash Flow | 30.17 | 26.99 | 56.83 | 43.87 | 44.12 |
Operating Cash Flow Growth | 11.78% | -52.51% | 29.55% | -0.55% | 61.56% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -130.44 | -48.27 | -56.43 | -30.97 | -46.85 |
Sale of Property, Plant & Equipment | 0.12 | 0.38 | 0.73 | 0.09 | 0.2 |
Other Investing Activities | 6.65 | 7.98 | 18.87 | 8.93 | 7.3 |
Investing Cash Flow | -123.67 | -39.92 | -36.83 | -21.94 | -39.36 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 114.3 | - | - | - | - |
Long-Term Debt Repaid | -15.79 | -12.31 | -22.65 | -5.68 | -4.14 |
Lease Payments | -15.79 | -12.31 | -22.65 | -5.68 | -4.14 |
Net Debt Issued (Repaid) | 98.5 | -12.31 | -22.65 | -5.68 | -4.14 |
Common Dividends Paid | -0.12 | -0.11 | -10.12 | -10.4 | -10.34 |
Other Financing Activities | -8.13 | -3.55 | -0.97 | -0.98 | -1.28 |
Financing Cash Flow | 90.26 | -15.97 | -33.74 | -17.05 | -15.75 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | -20.18 | -21.4 | -43.88 | - | - |
Net Cash Flow | -23.43 | -50.29 | -57.61 | 4.88 | -10.99 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -100.27 | -21.28 | 0.4 | 12.9 | -2.73 |
Free Cash Flow Growth | - | - | -96.88% | - | - |
Free Cash Flow Margin | -18.67% | -4.29% | 0.08% | 2.74% | -0.70% |
Free Cash Flow Per Share | -4.99 | -1.04 | 0.02 | 0.62 | -0.13 |
Levered Free Cash Flow | -92.85 | -19 | 5.45 | 1.88 | -7.16 |
Unlevered Free Cash Flow | -87.98 | -16.79 | 6.05 | 2.49 | -6.36 |
Free Cash Flow After Leases | -116.06 | -33.59 | -22.24 | 7.22 | -6.87 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 8.13 | 3.55 | 0.97 | 0.98 | 1.28 |
Cash Income Tax Paid | 3.05 | 6.25 | 12.57 | 14.1 | 8.46 |
Change in Working Capital | -5.69 | -6.13 | 0.44 | -20.42 | -7.45 |